The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity.
There is limited literature addressing the safety of administering electroconvulsive therapy (ECT) to patients concomitantly receiving bupropion monotherapy or in combination with other drugs that may alter the seizure threshold. We describe a prolonged seizure occurring during the first treatment of a course of ECT in an adult patient receiving long-term bupropion therapy, lithium, and venlafaxine.
Conway
C R
CR
Department of Psychiatry, St. Louis University, St. Louis, Missouri 63104, USA.
Nelson
L A
LA
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016642:Bupropion / Q000009:adverse effects* / Q000627:therapeutic use; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012640:Seizures / Q000209:etiology* / Q000503:physiopathology; D013997:Time Factors; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D018692:Antimanic Agents; D003511:Cyclohexanols; D016642:Bupropion; D016651:Lithium Carbonate; D000069470:Venlafaxine Hydrochloride